Connect Biopharmaceuticals Company
Connect Biopharmaceuticals is a developer of novel immune modulators for the treatment of serious autoimmune diseases and inflammation.
Technology:
Others
Industry:
PharmTech
Headquarters:
Taicang, Hebei, China
Founded Date:
2012
Employees Number:
1-10
Funding Status:
IPO
Estimated Revenue:
Less than $1M
Register and Claim Ownership